The Cancer

Don't Miss

News

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

Editor -
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor -
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor -
Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...
Load more

Vital Information

Load more

Facts

Latest Articles

Brain

IIT-D analysis on mind most cancers treatment reveals constructive leads to pre-clinical trials

Editor -
NEW DELHI: Sufferers recognized with glioblastoma (Mind tumour) sometimes have a life expectancy of 12–18 months post-diagnosis. Nonetheless, researchers at IIT Delhi have...
Treatment

‘Full circle second:’ Former UF Well being CEO has most cancers eradicated by program he helped carry to life – WOKV

Editor -
‘Full circle second:’ Former UF Well being CEO has most cancers eradicated by program he helped carry to life  WOKV
Research

A $9.54 Billion Market by 2030, Registering a Forecasted CAGR of 10.5%

Editor -
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "World Most cancers Stem Cells Market by Sort (Grownup Stem Cell, Human Embryonic Stem Cell,...
Stomach

Toby Keith’s Will Was Written Simply Months After Revealing Abdomen Most cancers Prognosis to the World

Editor -
After revealing his abdomen most cancers prognosis to his followers in June 2022, Toby Keith finalized his will on December 15, 2022. Courtroom...
Breast

Multiparametric MRI–primarily based radiomic fashions for early prediction of response to neoadjuvant systemic remedy in triple-negative breast most cancers

Editor -
Research cohort choiceOur research inhabitants consisted of 163 sufferers who have been enrolled from Might 2018 to July 2021 in potential medical trial...
1...1,1381,1391,140...1,671Page 1,139 of 1,671

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.